GI CONNECT has summarised the highlights from the ASCO GI 2020 meeting for you. Dr Yu Sunakawa (Japan) provides the highlights on cancer of the liver, small intestine and pancreas tract.
Oncology
GI CONNECT Update from ASCO GI 2020
Episode 2: Cancers of the liver, small intestine and pancreas tract
Publication Date
Sep 2021
Dr Yu Sunakawa is a medical oncologist at St. Marianna University, Japan and previously worked as an instructor at Showa University Northern Yokohama Hospital in Yokohama, Japan. He also completed postdoctoral research fellowship training at University of Southern California/Norris Comprehensive Cancer Center in United States. In 2011, Dr Sunakawa received the board certification of the Japanese Society of Medical Oncology. Dr Sunakawa’s research interests are the identification and determination of molecular markers in cancerous tissues or blood that could predict cancer risk and clinical outcome in gastrointestinal cancer. He is also focusing on research regarding tumour immunity and received a Merit Award from the American Society of Clinical Oncology in 2014, for the research of genetic variations in immune checkpoint-related genes.
Assoc. Prof. Yu Sunakawa has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Bayer, Bristol-Myers, Biopharma, Chugai Pharm, Daiichi-Sankyo, Gurdant, Lilly, Ono Pharm, Sanofi, Sysmex, Takeda and Tahio Pharm.
Download slides PDF 
Programme summary
Duration 5 MIN- Downloadable resources Yes
-
Download slides PDF
- Language(s)
Duration 
Language(s) 
Other episodes in this series
Episode 1: Cancers of the lower GI tract
GI CONNECT Update from ASCO GI 2020
Episode 2: Cancers of the liver, small intestine and pancreas tract Current Episode
Episode 3: Cancers of the upper GI tract
GI CONNECT Update from ASCO 2020
Episode 4: GI cancer highlights
Share this programme
Brought to you by
GI CONNECT is an initiative of COR2ED, supported by Independent Medical Educational Grants from Bayer and BeiGene Europe.
Meet the expertsOther programmes of interest
Video
Oncology
Celebrating the 10th anniversary of GI CONNECT
10 years of independent medical education in GI oncology
Experts
Assoc. Prof. Gerald Prager, Assoc. Prof. Joleen Hubbard, Dr Thomas Winder, Prof. Andrea Sartore-Bianchi, Dr Dominik Modest-
2 MIN
-
Apr 2024
2 MIN
Apr 2024
Tweetorial
Oncology
Tweetorial video: Treating ER+/HER2-low metastatic breast cancer, 2L and beyond
Journey through a patient case from testing and diagnosis to treatment and AE management
Experts
Dr Aditya BardiaEndorsed by
-
11 MIN
-
Apr 2024
Podcast
Oncology
Perseverance in molecular testing in NSCLC pays off
Looking beyond the obvious mutations in non-small-cell lung cancer
Experts
Prof. Frédérique Penault-Llorca, Prof. Mark Socinski-
Downloadable
Resources -
26 MIN
-
Mar 2024
Downloadable 
Conference update
Oncology
ER+ advanced breast cancer: Highlights from EBCC-14 satellite symposium
Medical experts discuss current and upcoming treatment strategies to use after CDK4/6 inhibitors in patients with ER+/HER2- advanced breast cancer
Experts
Prof. Valentina Guarneri, Prof. Matteo Lambertini, Prof. Federico Rojo-
Downloadable
Resources -
6 MIN
-
Mar 2024
Podcast
Oncology
mCRC: Optimising patient outcomes with late-line treatment
Maximising outcomes for patients with advanced CRC
Experts
Assoc. Prof. Gerald Prager, Dr Victor Hugo Fonseca de JesusEndorsed by
-
Downloadable
Resources -
23 MIN
-
Mar 2024
Interactive patient case
Oncology
TRK fusion-positive lung cancer: Diagnosis and treatment
Make decisions for your patient at two key stages in their journey
Experts
Prof. Fernando López-Ríos, Prof. Mark Socinski-
60 MIN
-
Mar 2024
